BioCC OÜ started developing a new type of a food supplement for the Asian market. In cooperation with the Latvian partner Lotos Pharma SIA the new product will combine the benefits of fibres used as prebiotics and BioCC’s patented live lactic acid bacteria used as probiotics. The product is expected to be released later in year 2021. This project is funded from Interreg Estonia-Latvia programm.

This article reflects the views of the author. The managing authority of the programme is not liable for how this information may be used.

Read more about the project here: https://biocc.eu/reasearch/projects-and-funding/